Article
Exploring the Comorbidity Mechanisms Between Asthma and Idiopathic Pulmonary Fibrosis and the Pharmacological Mechanisms of Bu-Shen-Yi-Qi Decoction Therapy via Network Pharmacology
2021-10-08
Abstract excerpt
<h4>Backgrounds: </h4> . Asthma and idiopathic pulmonary fibrosis (IPF) are common chronic diseases of the respiratory system in clinical practice. However, the relationship and molecular links between them remain unclear, and the current treatment's efficacy is disappointing. Bu-Shen-Yi-Qi (BSYQ) decoction has clinically proved to be effective in treating various chronic airway inflammatory diseases, including as...
Topics
Open a Topic to create a Post that cites this publication.
- Asthma and respiratory diseases
- Cancer-related molecular mechanisms research
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Computational Drug Discovery Methods
- Ferroptosis and cancer prognosis
- IL-33, ST2, and ILC Pathways
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Metabolomics and Mass Spectrometry Studies
Identifiers and source
- Literature Corpus work
- 31381c88-04cb-5ae4-903c-7b555849c109
- DOI
- 10.21203/rs.3.rs-898301/v1
